Skip to Main Content

2,011

Views

0

CrossRef citations to date

0

Altmetric

HPV – Research Article

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants

Suzanne M. Garlanda Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Victoria, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;c Centre for Women’s Infectious Diseases Research, The Royal Women’s Hospital, Parkville, Victoria, AustraliaView further author information

,

Manjula Anaganid Woman and Child Institute, CARE Super Specialty Hospital & Transplant Centre, Hyderabad, IndiaView further author information

,

Neerja Bhatlae Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, IndiaView further author information

,

Sukanta Chatterjeef Department of Pediatrics, KPC Medical College & Hospital, Kolkata, IndiaView further author information

,

Sanjay Lalwanig Lalwani Mother & Child Care Hospital, Pune, IndiaView further author information

,

Cecil Rossh Department of Chest Medicine & Hematology, St. John’s Medical College Hospital, Bangalore, IndiaView further author information

,

Thomas Groupi Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Jianxin Lini Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Alain Luxembourgi Merck & Co., Inc., Rahway, NJ, USAView further author information

,

Anuj Waliai Merck & Co., Inc., Rahway, NJ, USAView further author information

&

Yingmei Tui Merck & Co., Inc., Rahway, NJ, USACorrespondence[email protected]
View further author information